查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552565

药物传输和基因输送设备的市场规模、份额和趋势分析报告：按给药途径、媒介、地区和细分市场预测，2024-2030年

Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

药物传输和基因传输设备市场成长和趋势：

根据 Grand View Research, Inc. 的最新报告，预计 2030 年全球药物递送和基因递送市场规模将达到 12.2 亿美元，2024 年至 2030 年复合年增长率为 9.0%。

市场成长的驱动力是市场参与企业增加投资开发创新的药物输送系统，以满足患者需求并以最小的原料药数量提高生物有效性。此外，鑑于基因疗法在治疗多种疾病方面的高成长潜力，对基因递送系统研究和开发的日益关注预计将刺激未来市场的成长。

随着患者偏好的变化，药物输送系统也不断发展。例如，荷尔蒙补充疗法最初以锭剂形式广泛使用，现在以预填充式注射器、贴片、避孕环、凝胶和喷雾剂的形式提供。开发各种形式的交付系统的主要目的是提高易用性。在设计药物输送系统时，也考虑输送系统的美观、价格和原料药的数量等因素。

药物传输和基因输送设备市场报告亮点：

  • 2023年，口服剂型细分市场占据主导地位，由于其方便和易于给药，占据了最大的收益占有率，达到52.7%。
  • 由于危及生命的疾病的盛行率不断上升以及注射给药装置的进步，预计注射剂领域在预测期内的复合年增长率将达到 11.0%。
  • 2023年，由于患有慢性病的人数不断增加，北美以54.0%的销售份额主导药物和基因递送市场。
  • 亚太地区药物输送市场预计在预测期内将成长。这种增长是由于生活方式的改变以及酒精和烟草消费量的增加导致心臟病、糖尿病和癌症等慢性疾病的盛行率不断增加。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章药物传输和基因传输设备市场的变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 药物传输与基因传递设备市场分析工具
    • 波特的分析
    • PESTEL分析

第 4 章 药物传递与基因传递设备市场：依给药途径的估计与趋势分析

  • 细分仪表板
  • 药物传递与基因传递装置：2023 年及 2030 年依给药途径进行的前景分析
  • 口服
  • 吸入
  • 经皮的
  • 注射
  • 眼科
  • 鼻腔
  • 外用

第五章药物传输与基因传递设备市场：向量估计与趋势分析

  • 细分仪表板
  • 药物传输与基因传递设备市场：Vector 分析，2023 年和 2030 年
  • 病毒
  • 非病毒

第六章 药物传输与基因传递设备市场：区域估计与趋势分析

  • 2023 年和 2030 年药物传输和基因输送设备市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Uniqure NV,
    • SiBiono GeneTech Co.
    • Epeius Biotechnologies Corporation
    • Shanghai Sunway Biotech Co., Ltd
    • Pfizer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Johnson and Johnson
    • Novartis AG
    • Bayer AG
    • Becton, Dickinson and Company
简介目录
Product Code: GVR-1-68038-238-9

Drug And Gene Delivery Devices Market Growth & Trends:

The global drug and gene delivery devices market size is expected to reach USD 1.22 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.

Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.

Drug And Gene Delivery Devices Market Report Highlights:

  • In 2023, the oral segment dominated the market and accounted for the largest revenue share of 52.7%, owing to its convenience and ease of administration.
  • The injectable segment is expected to witness the fastest CAGR of 11.0% during the forecast period, fueled by increasing prevalence of life-threatening diseases and advancement in injectable drug delivery devices.
  • In 2023, North America dominated the drug and gene delivery devices market with a revenue share of 54.0%, owing to the rising number of people suffering from chronic diseases.
  • The drug and gene delivery devices market in Asia Pacific is projected to witness growth during the forecast period. The growth can be attributed to the increasing prevalence of chronic diseases such as heart disease, diabetes and cancer owing to the changing lifestyle, increase in consumption of alcohols and cigarettes.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Drug and Gene Delivery Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Drug and Gene Delivery Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Drug and Gene Delivery Devices Market: Route of Administration Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Drug and Gene Delivery Devices: Route of Administration Outlook Analysis, 2023 & 2030 (USD Million)
  • 4.3. Oral
    • 4.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Inhalation
    • 4.4.1. Inhalation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Transdermal
    • 4.5.1. Transdermal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Injectable
    • 4.6.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Ocular
    • 4.7.1. Ocular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Nasal
    • 4.8.1. Nasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Topical
    • 4.9.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Drug and Gene Delivery Devices Market: Vector Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Drug and Gene Delivery Devices Market: Vector Analysis, 2023 & 2030 (USD Million)
  • 5.3. Viral
    • 5.3.1. Viral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Non-Viral
    • 5.4.1. Non-Viral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Drug and Gene Delivery Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Drug and Gene Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Uniqure N.V.,
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. SiBiono GeneTech Co.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Epeius Biotechnologies Corporation
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Shanghai Sunway Biotech Co., Ltd
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Pfizer, Inc.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. F. Hoffmann-La Roche Ltd.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
    • 7.4.7. Johnson and Johnson
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Novartis AG
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Bayer AG
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Becton, Dickinson and Company
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives